查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572217

全球噬菌体市场：按类型、产品、形式、交付方式、应用、最终用户 - 预测 2025-2030

Bacteriophage Market by Type (Lysogenic, Lytic), Product (Phage Diagnostic Products, Phage Research Tools, Phage Therapy Products), Form, Delivery Mode, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年全球噬菌体市场价值为4774万美元，预计2024年将达到5015万美元，预计2030年将达到6835万美元，复合年增长率为5.26%。

噬菌体是一种感染并裂解特定细菌的病毒，因其作为对抗抗生素抗药性感染疾病和控制微生物组的精密工具的潜力而受到关注。随着对替代抗菌治疗的需求不断增长，在解决抗生素抗药性危机的需求和对个人化医疗日益增长的兴趣的推动下，全球噬菌体市场预计将扩大。应用范围广泛，包括医疗保健、农业和食品安全，其中噬菌体用于增强作物保护和防止食品腐败。最终使用范围主要是医院、诊所、研究机构和农业部门。关键的成长要素包括对噬菌体疗法认识的提高、客製化噬菌体解决方案的基因工程的进步以及各国为简化市场准入而提供的监管支持。然而，市场开拓受到高昂的开发成本、复杂的核准和法律规范以及医疗保健专业人员认知度低的限制。此外，虽然噬菌体特异性是一个优势，但它也可能是一个挑战，因为它需要针对每种细菌菌株的专门解决方案。最新的潜在商机包括开发合成噬菌体和联合治疗、与农业部门建立基于噬菌体的生物农药的伙伴关係以及扩大噬菌体库以涵盖更广泛的传染性病原体。建议包括投资有针对性的行销宣传活动以提高医疗保健相关人员的接受度、促进与生物技术公司的合作伙伴关係以简化生产以及实现应用组合多样化，其中包括寻求与多个地区的合作伙伴关係。儘管面临挑战，合成生物学的进步和输送系统的创新等领域仍提供了巨大的差异化机会。噬菌体-宿主相互作用的研究和噬菌体稳定性的最佳化可能会进一步增加商业性可行性。了解当地市场变化和监管环境对于利用当地商机至关重要，而递送机制和噬菌体配方的持续创新是在这个快速成长的市场中发展业务的最佳途径。

主要市场统计
基准年[2023] 4774万美元
预测年份 [2024] 5015万美元
预测年份 [2030] 6835万美元
复合年增长率（%） 5.26%

市场动态：揭示快速发展的全球噬菌体市场的关键市场洞察

全球噬菌体市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 抗生素抗药性细菌感染疾病的流行推动了全球噬菌体疗法的需求
    • 加大研发投入，推动噬菌体在全球医疗保健领域的应用
    • 越来越多的人认识到并接受噬菌体世界是抗生素的可行替代品
    • 扩大噬菌体在提高食品安全和农业生产力的全球应用
  • 市场限制因素
    • 医疗保健专业人员和患者对噬菌体疗法的认识和接受度较低
    • 与现有抗生素治疗的激烈竞争限制了噬菌体的全球治疗采用
  • 市场机会
    • 透过与製药公司合作加速全球噬菌体药物开发平臺
    • 将噬菌体世界应用于兽医学，以改善动物健康和食品生产
    • 噬菌体整体疗法以及与常规抗生素合併使用的协同效应
  • 市场挑战
    • 噬菌体全局治疗缺乏标准化方案阻碍了临床采用和一致性。
    • 噬菌体具有高度特异性，必须针对不同的细菌菌株单独开发。

波特五力：开拓全球噬菌体市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对全球噬菌体市场的外部影响

外部宏观环境因素在塑造全球噬菌体市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解全球噬菌体市场竞争状况

全球噬菌体市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

全球FPNV定位矩阵噬菌体市场供应商绩效评估

FPNV定位矩阵是评估全球噬菌体市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製全球噬菌体市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对全球噬菌体市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 抗生素抗药性病菌感染的增加正在推动噬菌体全球治疗的需求
      • 加大噬菌体医疗保健全球应用研发投入
      • 大众对噬菌体作为抗生素可行替代品的认识和接受度正在提高
      • 扩大噬菌体在提高食品安全和农业生产力的全球应用
    • 抑制因素
      • 医疗保健专业人员和患者对噬菌体全球疗法的认识和接受度有限
      • 与现有抗生素治疗的激烈竞争限制了噬菌体全球疗法的采用
    • 机会
      • 旨在与製药公司合作加速药物开发平臺
      • 在兽医领域实施噬菌体的全球应用，以改善动物健康和食品生产
      • 利用噬菌体的整体疗法与传统抗生素结合以产生协同效应
    • 任务
      • 噬菌体全局治疗缺乏标准化通讯协定阻碍了临床采用和一致性
      • 噬菌体具有高度特异性，需要针对不同菌株进行单独开发
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章全球噬菌体市场：依类型

  • 溶原性
  • 溶解度

第七章噬菌体的全球市场：副产品

  • 噬菌体诊断产品
  • 噬菌体研究工具
  • 噬菌体治疗产品

第八章全球噬菌体市场：依形式

  • 液体
  • 固体的

第 9 章按递送方式分類的噬菌体全球市场

  • 可注射的
  • 口服
  • 话题

第十章全球噬菌体市场：依应用分类

  • 农业
  • 诊断
  • 治疗性的
    • 人性化治疗
    • 兽医治疗

第十一章全球噬菌体市场：依最终用户分类

  • 医院和诊所
  • 製药公司
  • 调查机构

第十二章：美洲噬菌体的世界市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太地区噬菌体全球市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第14章：欧洲、中东和非洲的噬菌体世界市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C03A9

The Bacteriophage Market was valued at USD 47.74 million in 2023, expected to reach USD 50.15 million in 2024, and is projected to grow at a CAGR of 5.26%, to USD 68.35 million by 2030.

Bacteriophages, viruses that infect and lyse specific bacteria, have garnered attention for their potential in combating antibiotic-resistant infections and as precision tools in microbiome modulation. With an escalating need for alternative antibacterial treatments, the bacteriophage market is set to expand, propelled by the necessity to address antibiotic resistance crises and growing interest in personalized medicine. Applications extend across healthcare, agriculture, and food safety, where bacteriophages are used to enhance crop protection and prevent food spoilage. The end-use scope predominantly covers hospitals, clinics, research institutes, and agricultural sectors. Key growth factors include increasing awareness of phage therapy, advancements in genetic engineering which allow for tailored phage solutions, and regulatory support in several countries easing market entry. However, the market faces limitations such as high costs of development, complex regulatory frameworks for approval, and limited awareness among healthcare professionals. Additionally, phages' specificity, while an advantage, can also pose a challenge as it necessitates tailored solutions for each bacterial strain. The latest potential opportunities lie in the development of synthetic phages and combination therapies, creating partnerships with agriculture sectors for phage-based biopesticides, and expanding phage libraries to cover a broader range of infectious pathogens. Recommendations include investing in targeted marketing campaigns to increase acceptance among medical professionals, fostering collaborations with biotechnology firms to streamline production, and pursuing multi-regional partnerships to diversify application portfolios. Despite challenges, areas like synthetic biology advancements and delivery system innovations present ripe opportunities for differentiation. Research into phage-host interactions and optimizing phage stability could further enhance commercial viability. Understanding regional market variations and regulatory landscapes will be crucial for capitalizing on local opportunities, while continuous innovation in delivery mechanisms and phage formulations offer the best avenues for business growth in this burgeoning market.

KEY MARKET STATISTICS
Base Year [2023] USD 47.74 million
Estimated Year [2024] USD 50.15 million
Forecast Year [2030] USD 68.35 million
CAGR (%) 5.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bacteriophage Market

The Bacteriophage Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of antibiotic-resistant bacterial infections driving demand for bacteriophage therapy
    • Rising investments in research and development for bacteriophage applications in healthcare
    • Growing public awareness and acceptance of bacteriophage as a viable alternative to antibiotics
    • Expansion of bacteriophage application in food safety and agricultural productivity enhancement
  • Market Restraints
    • Limited awareness and acceptance of bacteriophage therapy among healthcare professionals and patients
    • High competition from established antibiotic treatments limiting bacteriophage therapy adoption
  • Market Opportunities
    • Collaborating with pharmaceutical companies to accelerate bacteriophage drug development pipelines
    • Implementing bacteriophage use in veterinary medicine to improve animal health and food production
    • Utilizing bacteriophage therapies in combination with traditional antibiotics for synergistic effects
  • Market Challenges
    • Lack of standardized protocols for bacteriophage therapy impeding clinical adoption and consistency
    • High specificity of bacteriophages requiring individualized development for different bacterial strains

Porter's Five Forces: A Strategic Tool for Navigating the Bacteriophage Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bacteriophage Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bacteriophage Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bacteriophage Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bacteriophage Market

A detailed market share analysis in the Bacteriophage Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bacteriophage Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bacteriophage Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bacteriophage Market

A strategic analysis of the Bacteriophage Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bacteriophage Market, highlighting leading vendors and their innovative profiles. These include Adaptive Phage Therapeutics, AmpliPhi Biosciences Corporation, Armata Pharmaceuticals Inc., ContraFect Corporation, CYTOO S.A., Eligo Bioscience, EnBiotix Inc., Fixed-Phage Limited, Intralytix Inc., iNtRON Biotechnology, Locus Biosciences Inc., Micreos BV, Optipharm Co. Ltd., Phage International Inc., Phagelux Inc., Phagomed Biopharma GmbH, Pherecydes Pharma, Phico Therapeutics Ltd., Sexton Biotechnologies, and TechnoPhage SA.

Market Segmentation & Coverage

This research report categorizes the Bacteriophage Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Lysogenic and Lytic.
  • Based on Product, market is studied across Phage Diagnostic Products, Phage Research Tools, and Phage Therapy Products.
  • Based on Form, market is studied across Liquid and Solid.
  • Based on Delivery Mode, market is studied across Injectable, Oral, and Topical.
  • Based on Application, market is studied across Agricultural, Diagnostic, and Therapeutic. The Therapeutic is further studied across Human Therapeutic and Veterinary Therapeutic.
  • Based on End-User, market is studied across Hospitals and Clinics, Pharmaceutical Companies, and Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of antibiotic-resistant bacterial infections driving demand for bacteriophage therapy
      • 5.1.1.2. Rising investments in research and development for bacteriophage applications in healthcare
      • 5.1.1.3. Growing public awareness and acceptance of bacteriophage as a viable alternative to antibiotics
      • 5.1.1.4. Expansion of bacteriophage application in food safety and agricultural productivity enhancement
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and acceptance of bacteriophage therapy among healthcare professionals and patients
      • 5.1.2.2. High competition from established antibiotic treatments limiting bacteriophage therapy adoption
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborating with pharmaceutical companies to accelerate bacteriophage drug development pipelines
      • 5.1.3.2. Implementing bacteriophage use in veterinary medicine to improve animal health and food production
      • 5.1.3.3. Utilizing bacteriophage therapies in combination with traditional antibiotics for synergistic effects
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized protocols for bacteriophage therapy impeding clinical adoption and consistency
      • 5.1.4.2. High specificity of bacteriophages requiring individualized development for different bacterial strains
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bacteriophage Market, by Type

  • 6.1. Introduction
  • 6.2. Lysogenic
  • 6.3. Lytic

7. Bacteriophage Market, by Product

  • 7.1. Introduction
  • 7.2. Phage Diagnostic Products
  • 7.3. Phage Research Tools
  • 7.4. Phage Therapy Products

8. Bacteriophage Market, by Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Solid

9. Bacteriophage Market, by Delivery Mode

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Bacteriophage Market, by Application

  • 10.1. Introduction
  • 10.2. Agricultural
  • 10.3. Diagnostic
  • 10.4. Therapeutic
    • 10.4.1. Human Therapeutic
    • 10.4.2. Veterinary Therapeutic

11. Bacteriophage Market, by End-User

  • 11.1. Introduction
  • 11.2. Hospitals and Clinics
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutions

12. Americas Bacteriophage Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Bacteriophage Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Bacteriophage Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adaptive Phage Therapeutics
  • 2. AmpliPhi Biosciences Corporation
  • 3. Armata Pharmaceuticals Inc.
  • 4. ContraFect Corporation
  • 5. CYTOO S.A.
  • 6. Eligo Bioscience
  • 7. EnBiotix Inc.
  • 8. Fixed-Phage Limited
  • 9. Intralytix Inc.
  • 10. iNtRON Biotechnology
  • 11. Locus Biosciences Inc.
  • 12. Micreos BV
  • 13. Optipharm Co. Ltd.
  • 14. Phage International Inc.
  • 15. Phagelux Inc.
  • 16. Phagomed Biopharma GmbH
  • 17. Pherecydes Pharma
  • 18. Phico Therapeutics Ltd.
  • 19. Sexton Biotechnologies
  • 20. TechnoPhage SA

LIST OF FIGURES

  • FIGURE 1. BACTERIOPHAGE MARKET RESEARCH PROCESS
  • FIGURE 2. BACTERIOPHAGE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BACTERIOPHAGE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BACTERIOPHAGE MARKET DYNAMICS
  • TABLE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE DIAGNOSTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE RESEARCH TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE THERAPY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BACTERIOPHAGE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BACTERIOPHAGE MARKET SIZE, BY HUMAN THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BACTERIOPHAGE MARKET SIZE, BY VETERINARY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BACTERIOPHAGE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BACTERIOPHAGE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 323. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 324. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2023